How to choose and compare between radiofrequency ablation and transarterial chemoembolization for recurrent hepatocellular carcinoma?

HPB (Oxford). 2017 Dec;19(12):1132. doi: 10.1016/j.hpb.2017.06.015. Epub 2017 Sep 29.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Carcinoma, Hepatocellular*
  • Catheter Ablation
  • Chemoembolization, Therapeutic
  • Combined Modality Therapy
  • Humans
  • Liver Neoplasms*
  • Treatment Outcome